CompletedPhase 4

Opioid-Free Shoulder Arthroplasty

United States86 participantsStarted 2016-09

Plain-language summary

Purpose of Study: To identify and provide a safe, opioid-free treatment pathway for shoulder arthroplasty with a focus on perioperative pain control and postoperative symptoms from treatment

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient undergoing elective primary total shoulder or reverse total shoulder arthroplasty for osteoarthritis, avascular necrosis, cuff tear arthropathy, or inflammatory arthritis etiologies
✓. Age greater than or equal to 50.

Exclusion criteria

✕. Revision total shoulder arthroplasty
✕. Chronic opioid therapy - per investigator discretion
✕. Liver or renal insufficiency - per investigator discretion
✕. Arthroplasty for fracture
✕. Sickle cell disease
✕. Workers compensation
✕. Inability to receive block
✕. Intervention Arm Only: Creatinine clearance less than 30 mL/min

What they're measuring

Post Op Pain

Timeframe: 24 hours

Trial details

NCT IDNCT03540030

SponsorOrthoCarolina Research Institute, Inc.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03

Results submitted2020-08-28

View on ClinicalTrials.gov More Opioid Use trials